BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31102236)

  • 1. Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient.
    Law N; Logan C; Yung G; Furr CL; Lehman SM; Morales S; Rosas F; Gaidamaka A; Bilinsky I; Grint P; Schooley RT; Aslam S
    Infection; 2019 Aug; 47(4):665-668. PubMed ID: 31102236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.
    Vickery SB; McClain D; Wargo KA
    Pharmacotherapy; 2016 Oct; 36(10):e154-e159. PubMed ID: 27522066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.
    Stefani S; Campana S; Cariani L; Carnovale V; Colombo C; Lleo MM; Iula VD; Minicucci L; Morelli P; Pizzamiglio G; Taccetti G
    Int J Med Microbiol; 2017 Sep; 307(6):353-362. PubMed ID: 28754426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.
    Ang JY; Abdel-Haq N; Zhu F; Thabit AK; Nicolau DP; Satlin MJ; van Duin D
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5627-30. PubMed ID: 27664282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
    Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.
    Smith DJ; Ramsay KA; Yerkovich ST; Reid DW; Wainwright CE; Grimwood K; Bell SC; Kidd TJ
    Respirology; 2016 Feb; 21(2):329-37. PubMed ID: 26711802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
    Taccetti G; Campana S; Festini F; Mascherini M; Döring G
    Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of parenteral colistin in treating of lower respiratory infection due to multidrug-resistant Pseudomonas aeruginosa].
    Endo R; Ishiguro N; Kikuta H
    Kansenshogaku Zasshi; 2005 Dec; 79(12):945-50. PubMed ID: 16444976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa.
    Tkhilaishvili T; Winkler T; Müller M; Perka C; Trampuz A
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31527029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.
    Trend S; Fonceca AM; Ditcham WG; Kicic A; Cf A
    J Cyst Fibros; 2017 Nov; 16(6):663-670. PubMed ID: 28720345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early clinical experience of bacteriophage therapy in 3 lung transplant recipients.
    Aslam S; Courtwright AM; Koval C; Lehman SM; Morales S; Furr CL; Rosas F; Brownstein MJ; Fackler JR; Sisson BM; Biswas B; Henry M; Luu T; Bivens BN; Hamilton T; Duplessis C; Logan C; Law N; Yung G; Turowski J; Anesi J; Strathdee SA; Schooley RT
    Am J Transplant; 2019 Sep; 19(9):2631-2639. PubMed ID: 31207123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.
    Saiman L
    Paediatr Respir Rev; 2007 Sep; 8(3):249-55. PubMed ID: 17868923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005405. PubMed ID: 17636796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Lung Transplantation for Cystic Fibrosis in the Setting of Extensively Drug-Resistant Organisms.
    Winstead RJ; Waldman G; Autry EB; Evans RA; Schadler A; Kays L; Baz M; Anstead MI; Shafii A; Goetz ME
    Prog Transplant; 2019 Sep; 29(3):220-224. PubMed ID: 31159656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
    Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
    Rutter WC; Burgess DR; Burgess DS
    Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage Therapy for Pan-Drug-Resistant
    Hahn A; Sami I; Chaney H; Koumbourlis AC; Del Valle Mojica C; Cochrane C; Chan BK; Koff JL
    J Investig Med High Impact Case Rep; 2023; 11():23247096231188243. PubMed ID: 37515541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of controlling drug-resistant Pseudomonas aeruginosa infection: experience from lung transplantation in a cystic fibrosis case.
    Yamamoto Y; Izumikawa K; Hara A; Fujita H; Amenomori M; Sakamoto N; Seki M; Kakeya H; Yanagihara K; Takasaki K; Miyazaki T; Tsuchiya T; Yamasaki N; Tagawa T; Nagayasu T; Kohno S
    Intern Med; 2010; 49(21):2353-8. PubMed ID: 21048374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.